Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA STRIDES PHARMA SCIENCE GSK PHARMA/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 62.2 -1,455.3 - View Chart
P/BV x 18.9 3.3 575.8% View Chart
Dividend Yield % 1.6 0.2 859.2%  

Financials

 GSK PHARMA   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
STRIDES PHARMA SCIENCE
Mar-23
GSK PHARMA/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs1,684392 429.3%   
Low Rs1,231263 467.1%   
Sales per share (Unadj.) Rs191.9408.5 47.0%  
Earnings per share (Unadj.) Rs35.9-25.6 -140.3%  
Cash flow per share (Unadj.) Rs39.81.4 2,905.7%  
Dividends per share (Unadj.) Rs32.001.50 2,133.3%  
Avg Dividend yield %2.20.5 479.9%  
Book value per share (Unadj.) Rs102.9242.8 42.4%  
Shares outstanding (eoy) m169.4190.30 187.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.60.8 945.9%   
Avg P/E ratio x40.6-12.8 -316.9%  
P/CF ratio (eoy) x36.7239.6 15.3%  
Price / Book Value ratio x14.21.4 1,049.1%  
Dividend payout %89.2-5.9 -1,520.8%   
Avg Mkt Cap Rs m246,85829,603 833.9%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9507,320 81.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51736,884 88.2%  
Other income Rs m1,0071,352 74.4%   
Total revenues Rs m33,52438,236 87.7%   
Gross profit Rs m8,033830 968.1%  
Depreciation Rs m6582,433 27.0%   
Interest Rs m182,611 0.7%   
Profit before tax Rs m8,364-2,862 -292.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288-553 -413.7%   
Profit after tax Rs m6,076-2,309 -263.2%  
Gross profit margin %24.72.2 1,098.1%  
Effective tax rate %27.419.3 141.5%   
Net profit margin %18.7-6.3 -298.5%  
BALANCE SHEET DATA
Current assets Rs m24,94331,353 79.6%   
Current liabilities Rs m13,26429,902 44.4%   
Net working cap to sales %35.93.9 913.3%  
Current ratio x1.91.0 179.4%  
Inventory Days Days9771 136.8%  
Debtors Days Days216129 167.9%  
Net fixed assets Rs m6,98831,300 22.3%   
Share capital Rs m1,694903 187.6%   
"Free" reserves Rs m15,73521,025 74.8%   
Net worth Rs m17,43021,928 79.5%   
Long term debt Rs m011,398 0.0%   
Total assets Rs m31,93063,734 50.1%  
Interest coverage x462.6-0.1 -482,087.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.00.6 176.0%   
Return on assets %19.10.5 4,022.4%  
Return on equity %34.9-10.5 -331.1%  
Return on capital %48.1-0.8 -6,396.0%  
Exports to sales %046.7 0.0%   
Imports to sales %48.10-   
Exports (fob) Rs mNA17,213 0.0%   
Imports (cif) Rs m15,630NA-   
Fx inflow Rs m1,62218,113 9.0%   
Fx outflow Rs m15,630672 2,327.5%   
Net fx Rs m-14,00817,442 -80.3%   
CASH FLOW
From Operations Rs m4,842444 1,090.3%  
From Investments Rs m8,0793,025 267.1%  
From Financial Activity Rs m-15,433-2,139 721.4%  
Net Cashflow Rs m-2,5121,328 -189.2%  

Share Holding

Indian Promoters % 0.0 27.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 38.9 29.8%  
FIIs % 2.9 19.5 15.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 72.6 34.4%  
Shareholders   114,663 91,182 125.8%  
Pledged promoter(s) holding % 0.0 69.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs STRIDES PHARMA SCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs STRIDES PHARMA SCIENCE Share Price Performance

Period GSK Pharma STRIDES PHARMA SCIENCE S&P BSE HEALTHCARE
1-Day 3.26% 1.16% 1.18%
1-Month -9.77% 0.35% -0.75%
1-Year 52.63% 176.88% 61.82%
3-Year CAGR 10.89% -3.35% 18.16%
5-Year CAGR 8.44% 10.98% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the STRIDES PHARMA SCIENCE share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of STRIDES PHARMA SCIENCE the stake stands at 27.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of STRIDES PHARMA SCIENCE.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

STRIDES PHARMA SCIENCE paid Rs 1.5, and its dividend payout ratio stood at -5.9%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of STRIDES PHARMA SCIENCE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.